Clinical Trial

Environmental Factors Associated With Peripheral Neuropathies in French Guiana

Study acronym: YANANER
Recruiting
View on ClinicalTrials.gov →
Summary
Peripheral neuropathies (PN) affect 1% of the global population, particularly the elderly. About 20-30% of cases remain unexplained. In French Guiana, we hypothesize that factors like neurotoxic traditional plant remedies, arboviral disease outbreaks, and mercury exposure from illegal gold mining may contribute to PN. The study aims to assess the association between PN and exposure to arboviral infections, heavy metals, and plant consumption in French Guiana.
Trial Details
NCT Number NCT07341997
Lead Sponsor Admin CIC
Conditions Peripheral Neuropathies, Environmental Risk Factor, Lead Neuropathy, Mercury Neuropathy, Bita
Enrollment 78 participants
Start Date 2025-12-08
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-15